Eimeria is a group of intracellular parasitic protozoa that are found in livestock, poultry and other animals. Its development can be divided into 3 stages: asexual reproduction, sexual reproduction and spore reproduction. Eimeria can cause huge economic losses to livestock and poultry breeding. Eimeria is also an important model organism for studying the biology and immunological characteristics of Eimeria. In recent years, with the rapid development of molecular biology, there has been a great breakthrough in the research of reverse genetic manipulation techniques such as transient transfection and screening of Eimeria. Meanwhile, the CRISPR/Cas9 system for gene editing of Eimeria crassa will also facilitate the study of the gene function of Eimeria crassa.
Ace Therapeutics, as a genome editing service provider, is focused on leveraging CRISPR/Cas9 technology and high-throughput screening to advance basic research and the pharmaceutical industry. We can provide CRISPR/Cas9 gene editing services for Eimeria coccinea to lay the foundation for in-depth elucidation of mechanistic studies.
We have a technical team with rich experience in CRISPR gene editing, and we can now realize one-stop service including gRNA design, CRISPR/Cas9 vector construction, transfection, and identification. After the service is completed, we will deliver you CRISPR/Cas9 gene editing products and detailed identification reports. If you want to know more, you are welcome to consult us.
Customers need to provide
Delivery content: experiment report, gene editing monoclonal cell lines, Eimeria or Eimeria animal models that edited by CRISPR/Cas9 technology
Test fee: please get it through online inquiry.
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.